EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in Non-Small Cell Lung Cancer
M Früh S Peters
Annals of Oncology, mdz185, https://doi.org/10.1093/annonc/mdz185

ΩτοΡινοΛαρυγγολόγος Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου